PIMA point-of-care CD4 testing and its impact on ART initiation, linkage to care and retentio

Not Applicable

Completed

• Conditions: HIV CD4 cell testing for care and treatment in primary health care; Infections and Infestations; Human immunodeficiency virus [HIV] disease

• Registration Number: ISRCTN14220457
• Lead Sponsor: niversity of KwaZulu-Natal

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35136596/ (added 10/02/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-06-11
• Study Completion: 2018-07-31
• Last Update Posted: 21 February 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 603

Inclusion Criteria

1. HIV positive adults not on ART
2. Patients willing to provide informed consent for samples to be tested

Exclusion Criteria

1. HIV negative patients
2. Children under 18 years old
3. Pregnant women
4. Patients on ART

Study & Design

• Study Type: Interventional
• Study Design: Not specified